China is advancing its "health silk road" in Africa by initiating major offshore projects to manufacture essential medicines, ...

Vertex Pharmaceuticals’ CRISPR-based therapy made history as the first drug of its type, transforming care options for sickle ...

Approximately 9.5 million people globally live with type 1 diabetes, a chronic autoimmune disease where T cells from the body ...

A new study by the University of California, Davis, shows how cells work together to avoid a sudden drop in blood sugar. Understanding these feedback loops could improve the lives of people with ...

A man with type 1 diabetes produces his own insulin after receiving genetically-modified donor islet cells, without the need ...

Nigeria is poised to host the continent’s first local insulin production facility, even as its aviation regulators move to ...

The difference between type 1 and type 2 diabetes is that people with type 2 have a wider variety of treatment options.

The best ways to treat diabetes include taking insulin, using medication like metformin, getting regular exercise, and ...

A 2-year follow-up of the randomized, placebo-controlled BANDIT trial shows that stopping baricitinib leads to a loss of ...

Advanced DNA sequencing technologies and a new model of stem cell research have enabled an international team to discover a ...